TriangleNCT00392327 · OUTCOME
Tumor Response to Radiation Therapy for Patients With Medulloblastoma
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of patients
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 12 weeks after treatment initiation
What was measured
Percentages of patients with responses after radiation therapy (induction therapy) are reported with 95% confidence intervals. Complete and partial responses were considered responses.
Analysis population: 83 of 87 eligible Arm A medulloblastoma patients were evaluated for response after induction, as were 85/89, 48/53, and 55/56 arm B, C, and D patients, respectively.
Groups in this outcome
Regimen A (Medulloblastoma Patients)
Medulloblastoma patients who received regimen A (no carboplatin / no isotretinoin)
Regimen B (Medulloblastoma Patients)
Medulloblastoma patients who received regimen B (carboplatin / no isotretinoin)
Regimen C (Medulloblastoma Patients)
Medulloblastoma patients who received regimen C (no carboplatin / isotretinoin)
Regimen D (Medulloblastoma Patients)
Medulloblastoma patients who received regimen D (carboplatin / isotretinoin)
| Group | Source count |
|---|---|
| Regimen A (Medulloblastoma Patients) | 83 |
| Regimen B (Medulloblastoma Patients) | 85 |
| Regimen C (Medulloblastoma Patients) | 48 |
| Regimen D (Medulloblastoma Patients) | 55 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Regimen A (Medulloblastoma Patients) | 75.9 | Not reported | 65.3 | 84.6 | Not reported |
| Regimen B (Medulloblastoma Patients) | 78.8 | Not reported | 68.6 | 86.9 | Not reported |
| Regimen C (Medulloblastoma Patients) | 72.9 | Not reported | 58.2 | 84.7 | Not reported |
| Regimen D (Medulloblastoma Patients) | 81.8 | Not reported | 69.1 | 90.9 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 65.3
- upper Limit
- 84.6
- value
- 75.9
- group Id
- OG001
- lower Limit
- 68.6
- upper Limit
- 86.9
- value
- 78.8
- group Id
- OG002
- lower Limit
- 58.2
- upper Limit
- 84.7
- value
- 72.9
- group Id
- OG003
- lower Limit
- 69.1
- upper Limit
- 90.9
- value
- 81.8
- denoms
- counts
- group Id
- OG000
- value
- 83
- group Id
- OG001
- value
- 85
- group Id
- OG002
- value
- 48
- group Id
- OG003
- value
- 55
- units
- Participants
- description
- Percentages of patients with responses after radiation therapy (induction therapy) are reported with 95% confidence intervals. Complete and partial responses were considered responses.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Medulloblastoma patients who received regimen A (no carboplatin / no isotretinoin)
- id
- OG000
- title
- Regimen A (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen B (carboplatin / no isotretinoin)
- id
- OG001
- title
- Regimen B (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen C (no carboplatin / isotretinoin)
- id
- OG002
- title
- Regimen C (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen D (carboplatin / isotretinoin)
- id
- OG003
- title
- Regimen D (Medulloblastoma Patients)
- param Type
- NUMBER
- population Description
- 83 of 87 eligible Arm A medulloblastoma patients were evaluated for response after induction, as were 85/89, 48/53, and 55/56 arm B, C, and D patients, respectively.
- reporting Status
- POSTED
- time Frame
- 12 weeks after treatment initiation
- title
- Tumor Response to Radiation Therapy for Patients With Medulloblastoma
- type
- SECONDARY
- unit Of Measure
- percentage of patients
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice